APU MS Biotechnology Program to launch training resources for certifications in quality assurance, regulatory affairs, project management and clinical trials for Fall, 2021.
(April 5, 2021) APU MS Biotechnology Program to launch training resources for certifications in quality assurance, regulatory affairs, project management and clinical trials for Fall, 2021. Exciting innovations in biotechnology, bioinformatics, and medical devices are driving an expanding job market in the biomedical products industries, and California is home to more than 50 percent of these companies. Azusa Pacific University’s Master of Biotechnology Program announced its intent to further equip professionals with focused training in areas critical to biomedical product development and manufacturing.
“We’re very excited about this additional program focus. The MS Biotechnology degree trains in business, science and technology and equips future leaders with the training they need for success in this expanding industry”, said MS Biotech Program Executive Director Dr. David Dyer. “Students starting in Fall, 2021, will be able to apply their training to formal certifications.”
The 39-unit applied masters program trains in key areas, including regulatory affairs, clinical trials, project management, and biomedical product manufacturing. Collaboration with lead regional and national biomedical product companies to give its students the in-person experience needed to advance careers in the industry.
APU’s biotech applied science master’s degree is designed for industry professionals and pre-preprofessionals, and offers evening courses with live-online and in-person options. More information about the program can be found at apu.edu/biotech.
